AstraZeneca CEO: COVID-19 vaccine may still have a role in U.S

LONDON (Reuters) - AstraZeneca still plans to seek approval for its COVID-19 vaccine in the United States even though the process is taking longer than expected, because it may still be used there in future, chief executive Pascal Soriot said on Thursday.

"The simple answer is, it's an important vaccine. And we believe it may play a role in the future, so we want to file and get approval for it," he said on a briefing, when asked why the drug maker was pursing approval even though...